The effects of aspirin on growth and COX-2 expression in prostate cancer cells

被引：0
|
作者：
Wang, R. [1 ]
Shah, U. K. [1 ]
Jenkins, G. [1 ]
Doak, S. [1 ]
机构：
[1] Swansea Univ, Sch Med, Inst Life Sci, Swansea, W Glam, Wales
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 61卷
关键词：
D O I：
10.1016/S0959-8049(16)61135-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
229
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [21] Bidirectional Regulation of COX-2 Expression Between Cancer Cells and Macrophages
    Carvalho, Maria Isabel
    Bianchini, Rodolfo
    Fazekas-Singer, Judit
    Herrmann, Ina
    Flickinger, Irene
    Thalhammer, Johann G.
    Pires, Isabel
    Jensen-Jarolim, Erika
    Queiroga, Felisbina L.
    ANTICANCER RESEARCH, 2018, 38 (05) : 2811 - 2817
  • [22] Oral but not parenteral aspirin upregulates COX-2 expression in rat stomachs: A causal relationship between COX-2 expression and prostaglandin deficiency
    Nishikawa, Kaoru
    Yokota, Aya
    Mashita, Yuji
    Taniguchi, Masaki
    Takeuchi, Koji
    GASTROENTEROLOGY, 2006, 130 (04) : A407 - A407
  • [23] COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin
    Holmes, Michelle D.
    Chen, Wendy Y.
    Schnitt, Stuart J.
    Collins, Laura
    Colditz, Graham A.
    Hankinson, Susan E.
    Tamimi, Rulla M.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (02) : 657 - 662
  • [24] COX-2 Expression and Effects of COX-2 Inhibition in Colorectal Carcinomas and their Liver Metastases
    Kasper, Hans-Udo
    Konze, Elisabeth
    Dienes, Hans Peter
    Stippel, Dirk Ludger
    Schirmacher, Peter
    Kern, Michael
    ANTICANCER RESEARCH, 2010, 30 (06) : 2017 - 2023
  • [25] COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin
    Michelle D. Holmes
    Wendy Y. Chen
    Stuart J. Schnitt
    Laura Collins
    Graham A. Colditz
    Susan E. Hankinson
    Rulla M. Tamimi
    Breast Cancer Research and Treatment, 2011, 130
  • [26] COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer
    Garg, Rachana
    Blando, Jorge M.
    Perez, Carlos J.
    Lal, Priti
    Feldman, Michael D.
    Smyth, Emer M.
    Ricciotti, Emanuela
    Grosser, Tilo
    Benavides, Fernando
    Kazanietz, Marcelo G.
    ONCOGENE, 2018, 37 (34) : 4735 - 4749
  • [27] COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer
    Rachana Garg
    Jorge M. Blando
    Carlos J. Perez
    Priti Lal
    Michael D. Feldman
    Emer M. Smyth
    Emanuela Ricciotti
    Tilo Grosser
    Fernando Benavides
    Marcelo G. Kazanietz
    Oncogene, 2018, 37 : 4735 - 4749
  • [28] Zyflamend®, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression
    Bemis, DL
    Capodice, JL
    Anastasiadis, AG
    Katz, AE
    Buttyan, R
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2005, 52 (02): : 202 - 212
  • [29] LLW-3-6 and Celecoxib Impacts Growth in Prostate Cancer Cells and Subcellular Localization of COX-2
    Yerokun, Tokunbo
    Winfield, Leyte L.
    ANTICANCER RESEARCH, 2014, 34 (09) : 4755 - 4759
  • [30] Saw Palmetto Berry Extract inhibits cell growth and Cox-2 expression in prostatic cancer cells
    Goldmann, WH
    Sharma, AL
    Currier, SJ
    Johnston, PD
    Rana, A
    Sharma, CP
    CELL BIOLOGY INTERNATIONAL, 2001, 25 (11) : 1117 - 1124
12345